Antibiotic Susceptibility Patterns of Bacterial Isolates from Routine Clinical Specimens from Referral Hospitals in Tanzania: A Prospective Hospital-Based Observational Study

References

• Leopold SJ, van Leth F, Tarekegn H, Schultsz C. Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a systematic review. J Antimicrob Chemother. 2014;69(9):2337–2353. doi:10.1093/jac/dku176.24879668
   PubMed Web of Science ®Google Scholar
• WHO. Prioritization of Pathogens to Guide Discovery, Research and Development of New Antibiotics for Drug Resistant Bacterial Infections, Including Tuberculosis. WHO; 2017.
   Google Scholar
• Naylor NR, Atun R, Zhu N, et al. Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrob Resist Infect Control. 2018;7(1):58. doi:10.1186/s13756-018-0336-y.29713465
   PubMed Web of Science ®Google Scholar
• O’Neill J. Antimicrobial Resistance: tackling a crisis for the health and wealth of nations 2014. Available from; https://wellcomecollection.org/works/rdpck35v. Accessed 112, 2021.
   Google Scholar
• Cantón R, Horcajada JP, Oliver A, Garbajosa PR, Vila J. Inappropriate use of antibiotics in hospitals: the complex relationship between antibiotic use and antimicrobial resistance. Enferm Infecc Microbiol Clin. 2013;31:3–11. doi:10.1016/S0213-005X(13)70126-5.24129283
   PubMedGoogle Scholar
• Mnyambwa PM, Kim D-J, Ngadaya ES, Kazwala R, Petrucka P, Mfinanga SG. Clinical implication of novel drug resistance-conferring mutations in resistant tuberculosis. Eur J Clin Microbiol Infect Dis. 2017;36:2021–2028. doi:10.1007/s10096-017-3027-3.28593375
   PubMed Web of Science ®Google Scholar
• Thomson KS. Extended-spectrum-β-lactamase, AmpC, and carbapenemase issues. J Clin Microbiol. 2010;48:1019–1025. doi:10.1128/JCM.00219-10.20181902
   PubMed Web of Science ®Google Scholar
• Madec JY, Haenni M, Nordmann P, Poirel L. Extended-spectrum β-lactamase/AmpC- and carbapenemase-producing Enterobacteriaceae in animals: a threat for humans? Clin Microbiol Infect. 2017;23:826–833. doi:10.1016/j.cmi.2017.01.013.28143782
   PubMed Web of Science ®Google Scholar
• Boyle DP, Zembower TR. Epidemiology and Management of Emerging Drug-Resistant Gram-Negative Bacteria: extended-Spectrum β-Lactamases and Beyond. Urol Clin North Am. 2015;42(4):493–505. doi:10.1016/j.ucl.2015.05.005.26475946
   PubMed Web of Science ®Google Scholar
• Laxminarayan R, Matsoso P, Pant S, et al. Access to effective antimicrobials: a worldwide challenge. Lancet. 2016;387:168–175. doi:10.1016/S0140-6736(15)00474-2.26603918
   PubMed Web of Science ®Google Scholar
• Low A, Gavriilidis G, Larke N, et al. Incidence of Opportunistic Infections and the Impact of Antiretroviral Therapy among HIV-Infected Adults in Low- and Middle-Income Countries: a Systematic Review and Meta-analysis. Clin Infect Dis. 2016;62(12):1595–1603. doi:10.1093/cid/ciw125.26951573
   PubMed Web of Science ®Google Scholar
• Mhada TV, Fredrick F, Matee MI, Massawe A. Neonatal sepsis at Muhimbili National Hospital, Dar es Salaam, Tanzania; aetiology, antimicrobial sensitivity pattern and clinical outcome. BMC Public Health. 2012;12(1):1. doi:10.1186/1471-2458-12-904.22214479
   PubMed Web of Science ®Google Scholar
• Maze MJ, Bassat Q, Feasey NA, Mandomando I, Musicha P, Crump JA. The epidemiology of febrile illness in sub-Saharan Africa: implications for diagnosis and management. Clin Microbiol Infect. 2018;24(8):808–814. doi:10.1016/j.cmi.2018.02.011.29454844
   PubMed Web of Science ®Google Scholar
• Said Aboud RM. GARP-Tanzania Situation Analysis and recommendation| antibiotics use and resistance in Tanzania 2015. Available from: http://www.cddep.org/publications/garp_tanzania_situation_analysis#sthash.mqdm17im.dpbs. Accessed 511, 2017.
   Google Scholar
• Clsi. M. 100 Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. 2017.
   Google Scholar
• Kumburu HH, Sonda T, Mmbaga BT, et al. Patterns of infections, aetiological agents and antimicrobial resistance at a tertiary care hospital in northern Tanzania. Trop Med Int Heal. 2017;22(4):454–464. doi:10.1111/tmi.12836.
   Web of Science ®Google Scholar
• Moremi N, Claus H, Mshana SE. Antimicrobial resistance pattern: a report of microbiological cultures at a tertiary hospital in Tanzania. BMC Infect Dis. 2016;16(1):756. doi:10.1186/s12879-016-2082-1.27964724
   PubMed Web of Science ®Google Scholar
• Mikomangwa WP, Bwire GM, Kilonzi M, et al. The Existence of High Bacterial Resistance to Some Reserved Antibiotics in Tertiary Hospitals in Tanzania: a Call to Revisit Their Use. Infect Drug Resist. 2020;Volume 13:1831–1838. doi:10.2147/IDR.S250158.
   Web of Science ®Google Scholar
• Tadesse BT, Ashley EA, Ongarello S, et al. Antimicrobial resistance in Africa: a systematic review. BMC Infect Dis. 2017;17(1):1–17. doi:10.1186/s12879-017-2713-1.28049444
   PubMed Web of Science ®Google Scholar
• Tesfa T, Mitiku H, Sisay M, et al. Bacterial otitis media in sub-Saharan Africa: a systematic review and meta-analysis. BMC Infect Dis. 2020;20(1):1–12. doi:10.1186/s12879-020-4950-y.
   Web of Science ®Google Scholar
• WHO. World Health Organization Model List of Essential Medicines. WHO; 2019.
   Google Scholar
• Ministry of Health, Community Development, Gender, Elderly and Children (MoHCDEC) (Tanzania): Standard treatment guidelines and essential medicines list for children and adolescents. 2018.
   Google Scholar
• Alemu A, Moges F, Shiferaw Y, et al. Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at University of Gondar Teaching Hospital, Northwest Ethiopia. BMC Res Notes. 2012;5.
   Google Scholar
• Moyo SJ, Aboud S, Kasubi M, Maselle SY. Bacterial isolates and drug susceptibility patterns of urinary tract infection among pregnant women at Muhimbili National Hospital in Tanzania. Tanzan J Health Res. 2010;12(4):233–236. doi:10.4314/thrb.v12i4.52997.
   Google Scholar
• Tan CW, Chlebicki MP. Urinary tract infections in adults. Singapore Med J. 2016;57(09):485–490. doi:10.11622/smedj.2016153.27662890
   PubMed Web of Science ®Google Scholar
• Hounmanou YMG, Leekitcharoenphon P, Kudirkiene E, et al. Genomic insights into Vibrio cholerae O1 responsible for cholera epidemics in Tanzania between 1993 and 2017. PLoS Negl Trop Dis. 2019;13:e0007934. doi:10.1371/JOURNAL.PNTD.0007934.31869327
   PubMed Web of Science ®Google Scholar
• McCrickard LS, Massay AE, Narra R, et al. Cholera mortality during urban epidemic, Dar es Salaam, Tanzania, August 16, 2015–January 16, 2016. Emerg Infect Dis. 2017;23(13):S154–7. doi:10.3201/eid2313.170529.
   Web of Science ®Google Scholar
• Urassa WK, Mhando YB, Mhalu FS, Mjonga SJ. Antimicrobial susceptibility pattern of Vibrio cholerae O1 strains during two cholera outbreaks in Dar es Salaam, Tanzania. East Afr Med J. 2000;77(7):350–353.12862151
   PubMed Web of Science ®Google Scholar
• Mushi MF, Mshana SE, Imirzalioglu C, Bwanga F. Carbapenemase genes among multidrug resistant gram negative clinical isolates from a tertiary hospital in Mwanza, Tanzania. Biomed Res Int. 2014;2014:2014. doi:10.1155/2014/303104.
   Web of Science ®Google Scholar
• Wi T, Lahra MM, Ndowa F, et al. Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action Summary points 2017. PLoS Med. 2017. 14(7):e1002344. doi:10.1371/journal.pmed.1002344.28686231
   PubMed Web of Science ®Google Scholar
• Wangai FK, Masika MM, Maritim MC, Seaton RA. Methicillin-resistant Staphylococcus aureus (MRSA) in East Africa: red alert or red herring? BMC Infect Dis. 2019;19(1):596. doi:10.1186/s12879-019-4245-3.31288757
   PubMed Web of Science ®Google Scholar
• Garoy EY, Gebreab YB, Achila OO, et al. Methicillin-Resistant Staphylococcus aureus (MRSA): prevalence and Antimicrobial Sensitivity Pattern among Patients - A Multicenter Study in Asmara, Eritrea. Can J Infect Dis Med Microbiol. 2019;2019:2019. doi:10.1155/2019/8321834.
   Web of Science ®Google Scholar